4.0989
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health - Quantisnow
Sana Biotechnology, Inc. (SANA) Stock Analysis: 89% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know - Yahoo Finance
Aug Levels: What are Sana Biotechnology Incs earnings expectationsEarnings Overview Summary & Daily Stock Trend Reports - baoquankhu1.vn
Is Sana Biotechnology Inc. a stock for growth or value investorsJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - mfd.ru
Sana Biotechnology, Inc. $SANA Position Boosted by Baillie Gifford & Co. - MarketBeat
Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet - Finviz
Fundamentals Check: Will Sana Biotechnology Inc benefit from sector rotationEarnings Performance Report & Smart Swing Trading Techniques - baoquankhu1.vn
Sell Signal: Is Sana Biotechnology Inc a stock for growth or value investorsJuly 2025 Update & High Conviction Buy Zone Alerts - baoquankhu1.vn
Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips (NASDAQ:SANA) - Seeking Alpha
Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics - Quantisnow
Bank of America Securities Reaffirms Their Buy Rating on Sana Biotechnology (SANA) - The Globe and Mail
Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 86.60% Upside in the Biotech Arena - DirectorsTalk Interviews
Institution Moves: What is the Moat Score of Sana Biotechnology IncEarnings Growth Summary & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Portfolio Shifts: Will Sana Biotechnology Inc stock hit new highs in YEAR2025 Risk Factors & Verified Short-Term Plans - baoquankhu1.vn
SANA: Gene-edited cell therapy for type 1 diabetes shows durable immune evasion; phase I trials planned - TradingView
Sana Biotechnology, Inc. Updates on Key Programs at J.P. Morgan Conference - TradingView
Sell Signal: Will Sana Biotechnology Inc stock hit new highs in YEARPortfolio Gains Report & Risk Controlled Stock Alerts - baoquankhu1.vn
Gains Report: Why Sana Biotechnology Inc stock attracts high net worth investorsWeekly Stock Summary & Long-Term Capital Growth Ideas - Bộ Nội Vụ
Sana Biotechnology to Present at June 2025 Investor Conferences - FinancialContent
Geopolitics Watch: Why Sana Biotechnology Inc stock attracts high net worth investorsEarnings Growth Summary & Weekly Stock Performance Updates - Bộ Nội Vụ
New Highs: How Sana Biotechnology Inc stock performs in stagflationJuly 2025 Macro Moves & Trade Opportunity Analysis - Bộ Nội Vụ
How rising interest rates impact Sana Biotechnology Inc. stockWalking Comfort Picks & compare fit, width, and feel - Улправда
Sana Biotechnology (SANA) Is Up 11.1% After BofA Endorsement And JPM Update Signal Boost - Sahm
Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum - Sahm
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
Can Sana Biotechnology Inc. stock sustain market leadershipMarket Rally & Stepwise Trade Signal Implementation - ulpravda.ru
Citizens Maintains Sana Biotechnology (SANA) Market Outperform Recommendation - MSN
Is Sana Biotechnology Inc. stock cheap compared to fundamentals2025 Pullback Review & Community Trade Idea Sharing Platform - ulpravda.ru
Can Sana Biotechnology Inc. stock sustain revenue growthQuarterly Portfolio Report & AI Based Trade Execution Alerts - ulpravda.ru
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Up 7.4% Following Analyst Upgrade - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Price Target Raised to $7.00 at Bank of America - MarketBeat
Buybacks Report: Can Sana Biotechnology Inc stock maintain operating marginsJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - moha.gov.vn
Big Picture: Can Sana Biotechnology Inc stock sustain market leadership - moha.gov.vn
Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Promising 110.6% Potential Upside - DirectorsTalk Interviews
Institutional Investors May Overlook Sana Biotechnology, Inc.'s (NASDAQ:SANA) Recent US$120m Market Cap Drop as Long-term Gains Remain Positive - 富途牛牛
Sana Biotechnology (NASDAQ:SANA) Shares Down 3.3%Time to Sell? - MarketBeat
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In Excitement - MSN
Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication - Finviz
Sana Biotechnology showcases successful in vivo gene editing of stem cells in Nature publication - MSN
Seattle InnoSana and Bothell I Following up with ZenLedger - The Business Journals
Corient Private Wealth LLC Has $3.10 Million Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
How Sana Biotechnology Inc. stock performs in weak economyJuly 2025 Technicals & Reliable Price Breakout Alerts - Улправда
Sana Biotechnology (NASDAQ:SANA) Upgraded at Wall Street Zen - MarketBeat
How resilient is Sana Biotechnology Inc. stock in market downturns2025 Top Decliners & Low Risk Entry Point Guides - Улправда
Can Sana Biotechnology Inc. stock maintain operating marginsWeekly Market Report & Stepwise Entry/Exit Trade Alerts - DonanımHaber
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 5.5%Here's What Happened - MarketBeat
CFO Wyrick Acquires 2,527 Of Sana Biotechnology Inc [SANA] - TradingView — Track All Markets
Sana Biotechnology, Inc. (SANA) insider details RSU vesting and stock sale - Stock Titan
Can Sana's Gene Editing Break New Ground In Treating Complex Diseases? - RTTNews
Marex Group plc Takes $10.42 Million Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):